Prostate Cancer Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Prostate Cancer Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Priliminary Tests and Confirmatory Tests)

Report Code: TIPRE00003656 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION
Prostate Cancer is an unusual and unbounded growth of cells in the prostate glands of the male. According to World Health Organization (WHO), prostate cancer is the second most common cancer in men. In 2012, an estimated 1.1 million men worldwide were diagnosed with prostate cancer, reckoning for 15% of the cancers diagnosed in men. With an estimated 307,000 deaths in 2012, prostate cancer is the fifth leading cause of death from cancer in men (6.6% of the total deaths among men).

MARKET DYNAMICS
The Prostate Cancer Diagnostics Market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of disease requiring surgical treatment, Increasing prevalence of Cancer and Hernia and growing number of bariatric surgeries etc. Growing healthcare expenditure and introduction of advanced technologies in minimally invasive surgeries, growing insurance coverage and inclination of the surgeons to prescribe minimally invasive surgeries to patients due to early post-operative recovery and lower post-operative complications are also likely to driven the market growth for the Ligation Devices Market during the forecast period.

MARKET SCOPE
The "Global Prostate Cancer Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Prostate Cancer Diagnostics Market with detailed market segmentation by Type, and geography. The global Prostate Cancer Diagnostics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Prostate Cancer Diagnostics Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Prostate Cancer Diagnostics Market is segmented on the basis of Type which is sub segmented as Preliminary Tests and Confirmatory Test. The Confirmatory Test segment is further sub segmented as PCA3 Tests, Trans Rectal ultrasound and Biopsy.

Get more information on this report :

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Prostate Cancer Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prostate Cancer Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Prostate Cancer Diagnostics Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prostate Cancer Diagnostics Market in these regions.

Get more information on this report :

MARKET PLAYERS
The reports cover key developments in the Prostate Cancer Diagnostics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers Prostate Cancer Diagnostics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Surgical Retractors in the global market. Below mentioned is the list of few companies engaged in the Surgical Retractors market.

The report also includes the profiles of key Prostate Cancer Diagnostics Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • MDxHealth
  • 3D Signatures
  • Genomic Health
  • Abbott
  • OPKO Health, INC.
  • Siemens Healthcare GmbH
  • DiaSorin S.p.A
  • BioMerieux SA
  • F. Hoffman La Roche Ltd.
  • Beckman Coulter, INC.
  • Myriad Genetic Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

TABLE OF CONTENTS


1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate Cancer Diagnostics Market - By Type
1.3.2 Prostate Cancer Diagnostics Market - By Region
1.3.2.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PROSTATE CANCER DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROSTATE CANCER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PROSTATE CANCER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE CANCER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. PROSTATE CANCER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PROSTATE CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PRELIMINARY TESTS
7.3.1. Overview
7.3.2. Preliminary Tests Market Forecast and Analysis
7.4. CONFIRMATORY TESTS
7.4.1. Overview
7.4.2. Confirmatory Tests Market Forecast and Analysis
7.4.3. PCA3 Tests Market
7.4.3.1. Overview
7.4.3.2. PCA3 Tests Market Forecast and Analysis
7.4.4. Trans Rectal Ultrasound Market
7.4.4.1. Overview
7.4.4.2. Trans Rectal Ultrasound Market Forecast and Analysis
7.4.5. Biopsy Market
7.4.5.1. Overview
7.4.5.2. Biopsy Market Forecast and Analysis
8. PROSTATE CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Prostate Cancer Diagnostics Market Overview
8.1.2 North America Prostate Cancer Diagnostics Market Forecasts and Analysis
8.1.3 North America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.1.4 North America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.1.4.1 United States Prostate Cancer Diagnostics Market
8.1.4.1.1 United States Prostate Cancer Diagnostics Market by Type
8.1.4.2 Canada Prostate Cancer Diagnostics Market
8.1.4.2.1 Canada Prostate Cancer Diagnostics Market by Type
8.1.4.3 Mexico Prostate Cancer Diagnostics Market
8.1.4.3.1 Mexico Prostate Cancer Diagnostics Market by Type
8.1.4.4 US Prostate Cancer Diagnostics Market
8.1.4.4.1 US Prostate Cancer Diagnostics Market by Type
8.2. EUROPE
8.2.1 Europe Prostate Cancer Diagnostics Market Overview
8.2.2 Europe Prostate Cancer Diagnostics Market Forecasts and Analysis
8.2.3 Europe Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.2.4 Europe Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Prostate Cancer Diagnostics Market
8.2.4.1.1 Germany Prostate Cancer Diagnostics Market by Type
8.2.4.2 France Prostate Cancer Diagnostics Market
8.2.4.2.1 France Prostate Cancer Diagnostics Market by Type
8.2.4.3 Italy Prostate Cancer Diagnostics Market
8.2.4.3.1 Italy Prostate Cancer Diagnostics Market by Type
8.2.4.4 Spain Prostate Cancer Diagnostics Market
8.2.4.4.1 Spain Prostate Cancer Diagnostics Market by Type
8.2.4.5 United Kingdom Prostate Cancer Diagnostics Market
8.2.4.5.1 United Kingdom Prostate Cancer Diagnostics Market by Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Prostate Cancer Diagnostics Market Overview
8.3.2 Asia-Pacific Prostate Cancer Diagnostics Market Forecasts and Analysis
8.3.3 Asia-Pacific Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.3.4 Asia-Pacific Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Prostate Cancer Diagnostics Market
8.3.4.1.1 Australia Prostate Cancer Diagnostics Market by Type
8.3.4.2 China Prostate Cancer Diagnostics Market
8.3.4.2.1 China Prostate Cancer Diagnostics Market by Type
8.3.4.3 India Prostate Cancer Diagnostics Market
8.3.4.3.1 India Prostate Cancer Diagnostics Market by Type
8.3.4.4 Japan Prostate Cancer Diagnostics Market
8.3.4.4.1 Japan Prostate Cancer Diagnostics Market by Type
8.3.4.5 South Korea Prostate Cancer Diagnostics Market
8.3.4.5.1 South Korea Prostate Cancer Diagnostics Market by Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Prostate Cancer Diagnostics Market Overview
8.4.2 Middle East and Africa Prostate Cancer Diagnostics Market Forecasts and Analysis
8.4.3 Middle East and Africa Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.4.4 Middle East and Africa Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Prostate Cancer Diagnostics Market
8.4.4.1.1 South Africa Prostate Cancer Diagnostics Market by Type
8.4.4.2 Saudi Arabia Prostate Cancer Diagnostics Market
8.4.4.2.1 Saudi Arabia Prostate Cancer Diagnostics Market by Type
8.4.4.3 U.A.E Prostate Cancer Diagnostics Market
8.4.4.3.1 U.A.E Prostate Cancer Diagnostics Market by Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Prostate Cancer Diagnostics Market Overview
8.5.2 South and Central America Prostate Cancer Diagnostics Market Forecasts and Analysis
8.5.3 South and Central America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.5.4 South and Central America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Prostate Cancer Diagnostics Market
8.5.4.1.1 Brazil Prostate Cancer Diagnostics Market by Type
8.5.4.2 Argentina Prostate Cancer Diagnostics Market
8.5.4.2.1 Argentina Prostate Cancer Diagnostics Market by Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. PROSTATE CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
10.1. MDXHEALTH
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. 3D SIGNATURES,INC.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. GENOMIC HEALTH
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. ABBOTT
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. OPKO HEALTH, INC
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. SIEMENS HEALTHCARE GMBH
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. DIASORIN S.P.A
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. BIOMERIEUX SA
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. F. HOFFMAN LA ROCHE LTD.
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. BECKMAN COULTER, INC
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
10.11. MYRIAD GENETIC INC
10.11.1. Key Facts
10.11.2. Business Description
10.11.3. Products and Services
10.11.4. Financial Overview
10.11.5. SWOT Analysis
10.11.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. MDxHealth
2. 3D Signatures
3. Genomic Health
4. Abbott
5. OPKO Health, INC.
6. Siemens Healthcare GmbH
7. DiaSorin S.p.A
8. BioMerieux SA
9. F. Hoffman La Roche Ltd.
10. Beckman Coulter, INC.
11. Myriad Genetic Inc
TIPRE00003656
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking